Play Earnings CallPlay Earnings Call
Elevance Health, Inc. (ELV) Barclays 28th Annual Global Healthcare Conference March 10, 2026 8:00 AM EDT
Company Participants
Mark Kaye – Executive VP & CFO
Conference Call Participants
Andrew Mok – Barclays Bank PLC, Research Division
Presentation
Andrew Mok
Barclays Bank PLC, Research Division
Hi. Good morning. My name is Andrew Mok. I’m the Facilities and Managed Care Analyst here at Barclays. Welcome to day 1 of the Barclays Global Healthcare Conference. I’m pleased to kick off today’s event with Elevance Health. And joining me on stage for today’s fireside chat is Mark Kaye, CFO, and Nate Rich, VP of IR. Welcome.
Mark Kaye
Executive VP & CFO
Thank you very much, Andrew. Pleasure to be here.
Question-and-Answer Session
Andrew Mok
Barclays Bank PLC, Research Division
Mark, there’s been a couple of notable recent developments at Elevance over the past few weeks. So I think it would be helpful for you to get your perspective on some of these issues. So first, as it relates to the CMS sanctions letter, what’s the scope of concerns raised by CMS in its communications with you? And what actions are you taking towards a resolution?
Mark Kaye
Executive VP & CFO
Andrew, that’s a great place to start. Let me start with the scope itself. So as outlined in CMS’ letter, the concerns that they’ve raised relate to certain historical risk adjustment data submission practices, specifically for dates of service prior to April 2023. And importantly, from our perspective, this is not simply a data submission issue. We view this as a broader policy and payment dispute, about how retroactive corrections should be treated under the risk adjustment framework that was in place during that period.
In terms of actions we’ve taken, we have approached this in good faith and with transparency. And given the
